Category: Uncategorized
The benefits of conducting clinical research in the vast geographical expanse of Latin America are numerous.
Mobile nurse visits enhance patient experiences.
Home visits for decentralized clinical trials (DCTs) in Latin America are different than in the U.S. or Europe. This image was recently taken by a nurse visiting a rural home in Brazil. The road is not paved. The weather conditions are harsh. And yet, when H Clinical is requested to quote home visits for patients […]
Applied Clinical Trials Magazine published an insightful article by H Clinical President Mitchell Parrish titled Game Changer: Transformative Decentralized Clinical Trials Emerge in Latin America. The benefits of conducting research in the region are many. This article uncovers how decentralized clinical trials (DCTs) enhance the likelihood of success for global clinical trials. Expanding patient recruitment while addressing diversity […]
Commercial home health is now part of the largest in-home trial, mobile site, logistics, and depot operations in Latin America (TAMPA, Fla., June 28, 2022) – H Clinical today announced it is extending industry-leading decentralized home health capabilities to include commercial product support for pharmaceutical organizations throughout Latin America. Commercial home health product visits entail […]
The expansion boosts in-home trial and mobile site support across Latin America by strengthening depot and logistics services for decentralized trials in Argentina, Brazil, Chile, Colombia, Mexico, Panama, and Peru (PR Newswire: TAMPA, Fla., March 8, 2022) – H Clinical today announced that the company is expanding logistics service capabilities to support decentralized clinical trials […]
It should come as no surprise that a key component of successful clinical research in the field is an effective supply chain and well-orchestrated clinical trial logistics. Whether you’re a drug manufacturer looking to run your own trial, or a sponsor looking for a trial operations company, it is wise to look at the supply […]
during the COVID-19 pandemic – and these benefits are why they will likely become an industry standard in the near future.
Latin America is heavily represented in cancer diagnosis statistics, but critically underrepresented in oncology clinical trials.
AstaZeneca is joining a growing body of pharmaceutical development companies to realize the multifaceted value of decentralized, at-home medical trials.